Genomic & Biopharma NewsSwiss scientists create artificial viruses to combat cancer cells
Swiss scientists from the University of Geneva, Switzerland, and the University of Basel have created artificial viruses that can be used to target cancer.
|News Medical Life Sciences, 2017-05-26 12:52:00|
Innate genetic advantage contributes to better outcomes in newborn infant girls than boys, research shows
Newborn infant girls have better outcomes than their male counterparts due to an innate genetic advantage in responding to acute infections, according to new research from RCSI.
|News Medical Life Sciences, 2017-05-26 12:47:00|
New NMR machine at TSRI’s Florida campus will help advance drug development process
The Nuclear Magnetic Resonance facility at the Florida campus of The Scripps Research Institute is becoming one of the most advanced in South Florida, thanks to a new $600,000 grant from the National Institutes of Health.
|News Medical Life Sciences, 2017-05-26 12:45:00|
Newly developed ultrafast cardiac imaging test changes clinical management in one-third of patients
Researchers in the UK and Peru have developed a faster and cheaper cardiac imaging test that can be used in developing countries, according to the results of the INCA-Peru study presented today at EuroCMR 2017.
|News Medical Life Sciences, 2017-05-26 12:44:00|
New FDA commissioner Gottlieb unveils price-fighting strategies
During the campaign and since the U.S. presidential election, President Donald Trump has pledged to bring down drug costs and, in some cases, railed against the industry for its pricing. Now, his new FDA commissioner is laying out some approaches the agency will take to fight high prices.
|Fierce Pharma, 2017-05-26 12:43:48|
LMD’s V-Sensor and app could reduce number of avoidable deaths in India
Leman Micro Devices, the developer of regulated consumer healthcare products that is backed by major players within the mobile device industry, has announced that its V-Sensor and app - the only smartphone-integrated solution that measures blood pressure and other vital signs with medical accuracy – will satisfy new requirements imposed by changes in laws governing the use of medical devices in India, and will therefore be suitable for use in the Indian market.
|News Medical Life Sciences, 2017-05-26 12:42:09|
Study: Combining non-invasive ventilation and home oxygen therapy can reduce hospital readmissions for chronic COPD patients
Recently published advancements in pulmonary research suggest that the combination of non-invasive ventilation and home oxygen therapy can significantly prolong time to readmission or death for patients with chronic obstructive pulmonary disease following a life-threatening respiratory event or exacerbation.
|News Medical Life Sciences, 2017-05-26 12:40:00|
Circulating tumor DNA evaluated as an alternative to tissue NGS for non-small cell lung cancer
Tissue biopsies, which are currently the gold standard molecular diagnostic technique for oncologists, are not only painful to cancer patients, but expose an already immune-comprised population to increased rates of nosocomial infections. Furthermore, it is not uncommon for the typical clinical pathology workflow to yield samples which are not suitable for routine analysis strategies, e.g.
|ORB Company Blog, 2016-10-21 17:26:00|
FIRS releases new report that outlines global burden of respiratory disease
The Forum of International Respiratory Societies, an organization comprised of the world’s leading international respiratory societies working together to improve lung health globally, today released “The Global Impact of Respiratory Disease.” The report lays out the tremendous impact that respiratory disease has on world health.
|News Medical Life Sciences, 2017-05-26 12:38:08|
FierceBiotech's 2016 Fierce 15
It's that time of year again when new school routines are established, deciduous trees begin their showy transformation, and FierceBiotech releases its annual list of 15 innovative companies who are primed to make a big splash in the biopharma industry.
|ORB Company Blog, 2016-09-23 17:22:41|
ERT’s Centralized LCI Services improve data quality to measure disease progression in respiratory clinical trials
ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today introduced an advanced respiratory clinical trial solution to centrally capture, measure and analyze Lung Clearance Index data, in near real-time, to assess lung performance with more precision than traditional spirometry measures.
|News Medical Life Sciences, 2017-05-26 12:36:39|